Crossref
EE147 COST EFFECTIVENESS OF EARLY VS DELAYED AUTOLOGOUS STEM CELL TRANSPLANTATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA
Value in Health · 2026-06 · 29 (6) · S90-S91
DOI: 10.1016/j.jval.2026.03.442 ↗Kurz gefasst
Fachartikel in der Zeitschrift Value in Health, 2026-06. Verfasst von Jacob Vang.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Vang, J. (2026). EE147 COST EFFECTIVENESS OF EARLY VS DELAYED AUTOLOGOUS STEM CELL TRANSPLANTATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA. Value in Health, 29(6), S90-S91. https://doi.org/10.1016/j.jval.2026.03.442
Vancouver
Vang J. EE147 COST EFFECTIVENESS OF EARLY VS DELAYED AUTOLOGOUS STEM CELL TRANSPLANTATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA. Value in Health. 2026;29(6):S90-S91. doi:10.1016/j.jval.2026.03.442
BibTeX
@article{Vang2026,
author = {Vang, Jacob},
title = {EE147 COST EFFECTIVENESS OF EARLY VS DELAYED AUTOLOGOUS STEM CELL TRANSPLANTATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA},
journal = {Value in Health},
year = {2026},
volume = {29},
number = {6},
pages = {S90--S91},
doi = {10.1016/j.jval.2026.03.442}
}
EUVIMED